GRAIL to Announce Fourth Quarter 2024 Financial Results
GRAIL (NASDAQ: GRAL) has announced it will release its fourth quarter 2024 financial results after market close on Thursday, February 20, 2025. The healthcare company, focused on early cancer detection, will follow the release with a management-hosted webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET.
The webcast will be accessible through GRAIL's investor relations website at investors.grail.com, with a recorded replay available afterward. Interested parties are advised to register at least ten minutes before the call's scheduled start time through the provided registration link.
GRAIL (NASDAQ: GRAL) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre 2024 dopo la chiusura del mercato giovedì 20 febbraio 2025. L'azienda sanitaria, focalizzata sulla rilevazione precoce del cancro, seguirà il rilascio con un webcast e una conferenza telefonica ospitati dalla direzione alle 13:30 PT / 16:30 ET.
Il webcast sarà accessibile tramite il sito web delle relazioni con gli investitori di GRAIL su investors.grail.com, con una registrazione disponibile successivamente. Le parti interessate sono invitate a registrarsi almeno dieci minuti prima dell'orario di inizio programmato della chiamata tramite il link di registrazione fornito.
GRAIL (NASDAQ: GRAL) ha anunciado que publicará sus resultados financieros del cuarto trimestre de 2024 después del cierre del mercado el jueves 20 de febrero de 2025. La empresa de salud, centrada en la detección temprana del cáncer, seguirá la publicación con un webcast y una llamada de conferencia organizada por la dirección a la 1:30 p.m. PT / 4:30 p.m. ET.
El webcast será accesible a través del sitio web de relaciones con inversores de GRAIL en investors.grail.com, con una grabación disponible posteriormente. Se aconseja a las partes interesadas que se registren al menos diez minutos antes de la hora programada de inicio de la llamada a través del enlace de registro proporcionado.
GRAIL (NASDAQ: GRAL)은 2024년 4분기 재무 결과를 2025년 2월 20일 목요일 시장 마감 후 발표할 예정이라고 발표했습니다. 조기 암 검진에 집중하는 이 헬스케어 회사는 발표 후 오후 1시 30분 PT / 오후 4시 30분 ET에 경영진 주최의 웹캐스트 및 컨퍼런스 콜을 진행할 것입니다.
웹캐스트는 GRAIL의 투자자 관계 웹사이트인 investors.grail.com을 통해 접근 가능하며, 이후에 녹화된 다시 보기가 제공됩니다. 관심 있는 분들은 제공된 등록 링크를 통해 전화 시작 예정 시간보다 최소 10분 전에 등록할 것을 권장합니다.
GRAIL (NASDAQ: GRAL) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre 2024 après la fermeture du marché le jeudi 20 février 2025. L'entreprise de santé, axée sur la détection précoce du cancer, suivra la publication par un webinaire et une conférence téléphonique animés par la direction à 13h30 PT / 16h30 ET.
Le webinaire sera accessible via le site web des relations investisseurs de GRAIL à investors.grail.com, avec un enregistrement disponible par la suite. Les parties intéressées sont invitées à s'inscrire au moins dix minutes avant l'heure de début prévue de l'appel via le lien d'inscription fourni.
GRAIL (NASDAQ: GRAL) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal 2024 nach Marktschluss am Donnerstag, den 20. Februar 2025, veröffentlichen wird. Das Gesundheitsunternehmen, das sich auf die frühzeitige Krebsdiagnose spezialisiert hat, wird der Veröffentlichung ein von der Geschäftsführung ausgerichtetes Webcast und eine Telefonkonferenz um 13:30 Uhr PT / 16:30 Uhr ET folgen lassen.
Das Webcast wird über die Investor-Relations-Website von GRAIL unter investors.grail.com zugänglich sein, mit einer späteren Aufzeichnung, die verfügbar sein wird. Interessierte Parteien werden gebeten, sich mindestens zehn Minuten vor dem geplanten Beginn der Konferenz über den bereitgestellten Registrierungslink anzumelden.
- None.
- None.
Fourth Quarter 2024 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.
Please register for the live event at https://grail-q4-financial-results-2024.open-exchange.net/.
To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-fourth-quarter-2024-financial-results-302375079.html
SOURCE GRAIL, Inc.
FAQ
When will GRAIL (GRAL) release its Q4 2024 earnings?
What time is GRAIL's (GRAL) Q4 2024 earnings call?
How can investors access GRAIL's (GRAL) Q4 2024 earnings call?
Will there be a replay available of GRAIL's (GRAL) Q4 2024 earnings call?
